CROTEDUMAB
UNII 4JQ68PW6XF

Substance Identification & Data

This profile provides standardized clinical and technical data for Crotedumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4JQ68PW6XF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1452387-69-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
4JQ68PW6XF
CAS Registry Number
1452387-69-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CROTEDUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C166762
National Cancer Institute reference terminology for clinical and research data.
INN ID
10196
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
BC-85
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Crotedumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CROTEDUMAB

Common Names & Synonyms

CROTEDUMAB [INN]
CROTEDUMAB [USAN]
CROTEDUMAB [WHO-DD]
IMMUNOGLOBULIN G4, ANTI-(HUMAN GLUCAGON RECEPTOR) (HUMAN MONOCLONAL REGN1193 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN1193 .KAPPA.-CHAIN, DIMER

Technical Codes

REGN1193
REGN-1193

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus